The UCLA Depression Grand Challenge was one of twelve organizations selected as a performer for the Wellcome-Leap Multi-Channel Psych program. The program, through a cross-disciplinary and cross-institutional collaborative effort, aims to develop better understanding about anhedonic depression, a severe and inhibitive kind of depression which affects the ability to feel pleasure or enjoyment. Wellcome Leap's approach is to build bridges between experts in different areas, and synchronize investigations across levels.
UCLA’s project, the Deep Phenotyping and Genetic Analysis of Anhedonia, aims to measure and track behavioral characteristics of depression with digital devices and use these measures to predict brain activity, as measured by MRI scans.
Read more about the MCPsych Program and other performers on the Wellcome Leap website.
Updated Sept. 28, 2022: Sign up to be screened as a research participant.
UCLA's research projects funded under this mechanism operate under the names OPTIMA & ILIAD.